Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a wrinkle injection smooth away the signs of aging?

NCT ID NCT06385171

Symptom relief Sponsor: Global Aesthetics LLC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This trial investigates whether botulinum toxin type A, commonly known as Botox, can safely reduce facial wrinkles. Adults aged 20 to 65 with forehead or frown-line wrinkles will receive injections, and doctors will assess changes using visual and photographic scales. The study aims to determine if this treatment is effective and well-tolerated for cosmetic wrinkle reduction.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Botulinum toxin type A (also known as OnabotulinumtoxinA), injected into facial wrinkles
What this could lead to
If successful, this could provide a safe, effective option for reducing facial wrinkles and improving appearance.
What could go wrong
This is an early-stage trial with a small number of participants. Results may not apply to everyone, and side effects like redness or inflammation can occur.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Started

May 2024

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The population from which the groups or cohorts will be selected consists of individuals aged between 20 and 65 years, regardless of gender, who are seeking treatment for facial wrinkles. These individuals must be in good physical health and exhibit both static (unchanging) and moderate dynamic (movement-induced) wrinkles on the forehead or glabellar region. They should also possess the willingness and ability to understand and provide informed consent for participation in the study. This population may include individuals from various backgrounds and demographics who are interested in cosmetic dermatology procedures.

Ages

20 to 65 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Individuals of both genders. * Must be in good physical health. * Age between 20 and 65 years. * Presence of both static (unchanging) and moderate dynamic (movement-induced) wrinkles on the forehead or glabellar region. * Must possess the willingness and ability to understand and provide informed consent, as well as effectively communicate with study personnel. Exclusion Criteria: * Pregnant or breastfeeding female. * Age below 20 or above 65 years. * History of neuromuscular disorders, such as myasthenia gravis. * History of facial surgery or presence of scars in the treatment area that could potentially interfere with or confound the results of the study. * Recent treatment history within the past 6 months in the forehead or glabellar region, including: * Ablative laser procedures. * Radiofrequency device treatments. * Ultrasound device treatments. * Medium to deep chemical peels. * Temporary soft tissue augmentation. * Semi-permanent soft tissue augmentation within the past 2 years. * Permanent soft tissue augmentation. * Planned cosmetic procedures within the next 6 months in the same region. * Intended use of tretinoin or retinoic acid within the next 6 months. * Presence of active infection in the treated area, excluding mild acne. * Allergy to cow's milk protein or albumin. * Use of aminoglycoside medications. * Current use of anticoagulation therapy. * History of bleeding disorders. * Diagnosis of mental illness. * Inability to comprehend the study protocol or provide informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Wrinkle are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Wrinkle

Contacts and locations

Locations

  • Global Aesthetics LLC

    Cisco, Texas, 76437, United States

  • Global Aesthetics LLC

    Lubbock, Texas, 79413, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.